ATE100495T1 - Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine. - Google Patents
Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine.Info
- Publication number
- ATE100495T1 ATE100495T1 AT89116679T AT89116679T ATE100495T1 AT E100495 T1 ATE100495 T1 AT E100495T1 AT 89116679 T AT89116679 T AT 89116679T AT 89116679 T AT89116679 T AT 89116679T AT E100495 T1 ATE100495 T1 AT E100495T1
- Authority
- AT
- Austria
- Prior art keywords
- virus
- fragment
- marek
- disease virus
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63226960A JP2583115B2 (ja) | 1988-09-10 | 1988-09-10 | 組換えマレック病ウイルスおよびその製法 |
EP89116679A EP0361182B1 (de) | 1988-09-10 | 1989-09-08 | Rekombinantes Marek-Krankheitsvirus, Verfahren zu seiner Herstellung, und Vakzine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE100495T1 true ATE100495T1 (de) | 1994-02-15 |
Family
ID=16853319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89116679T ATE100495T1 (de) | 1988-09-10 | 1989-09-08 | Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5171677A (de) |
EP (1) | EP0361182B1 (de) |
JP (1) | JP2583115B2 (de) |
AT (1) | ATE100495T1 (de) |
CA (1) | CA1339774C (de) |
DE (1) | DE68912478T2 (de) |
ES (1) | ES2061850T3 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634636A (en) * | 1983-12-13 | 1987-01-06 | Asahi Kasei Kogyo Kabushiki Kaisha | Polyacetylene composite |
US5965138A (en) * | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
US5961982A (en) * | 1985-09-06 | 1999-10-05 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
US5928648A (en) * | 1985-09-06 | 1999-07-27 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
NL9001828A (nl) * | 1990-08-15 | 1992-03-02 | Centraal Diergeneeskundig Inst | Werkwijze voor het wijzigen van het cel-, weefsel- of gastheertropisme van een microoerganisme; aldus verkregen gerecombineerd microorganisme en toepassing daarvan in de geneeskunde en diergeneeskunde. |
AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
US5853733A (en) * | 1993-02-26 | 1998-12-29 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
WO1995018860A1 (en) * | 1994-01-11 | 1995-07-13 | Cornell Research Foundation, Inc. | Control of marek's disease by the inhibition of latency and tumor cell development |
FR2728795B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
JPH08322559A (ja) * | 1995-06-02 | 1996-12-10 | Chemo Sero Therapeut Res Inst | gB遺伝子プロモーターを用いた組換えヘルペスウイルス |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US128836A (en) * | 1872-07-09 | Improvement in draught-regulators | ||
US4810634A (en) * | 1985-07-29 | 1989-03-07 | The Upjohn Company | Pseudorabies virus mutants incapable of producing glycoprotein X |
WO1987004463A1 (en) * | 1986-01-27 | 1987-07-30 | Syntro Corporation | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
WO1988007088A1 (en) * | 1987-03-19 | 1988-09-22 | Synergen, Inc. | Viral vector system for the introduction of foreign dna expression products into gallinaceous birds |
EP0332677B1 (de) * | 1987-07-27 | 1995-07-19 | Syntro Corporation | Attenuierte herpesviren, herpesviren, die für eine aminosäuresequenz kodierende fremde dns beeinhalten und sie enthaltende impfstoffe |
JP2779447B2 (ja) * | 1988-03-20 | 1998-07-23 | 財団法人阪大微生物病研究会 | 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体 |
-
1988
- 1988-09-10 JP JP63226960A patent/JP2583115B2/ja not_active Expired - Fee Related
-
1989
- 1989-09-08 ES ES89116679T patent/ES2061850T3/es not_active Expired - Lifetime
- 1989-09-08 DE DE89116679T patent/DE68912478T2/de not_active Expired - Lifetime
- 1989-09-08 CA CA000610801A patent/CA1339774C/en not_active Expired - Fee Related
- 1989-09-08 US US07/404,500 patent/US5171677A/en not_active Expired - Lifetime
- 1989-09-08 EP EP89116679A patent/EP0361182B1/de not_active Expired - Lifetime
- 1989-09-08 AT AT89116679T patent/ATE100495T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE68912478T2 (de) | 1994-05-11 |
CA1339774C (en) | 1998-03-24 |
US5171677A (en) | 1992-12-15 |
JP2583115B2 (ja) | 1997-02-19 |
JPH0276578A (ja) | 1990-03-15 |
EP0361182A1 (de) | 1990-04-04 |
ES2061850T3 (es) | 1994-12-16 |
DE68912478D1 (de) | 1994-03-03 |
EP0361182B1 (de) | 1994-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59611371D1 (de) | Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen | |
DE3485810D1 (de) | Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors. | |
KR910012233A (ko) | 칠면조의 재조합 포진바이러스와 그것에서 유도한 생존상태의 벡터 백신류 | |
DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
DE3855122T2 (de) | Artifizielles Gen, das für humane Serumalbumine kodiert, seine Verwendung und Verfahren zu seiner Herstellung | |
JPS60246317A (ja) | 鳥レトロウイルス‐牛生長ホルモンdnaで形質転換されたカプセルに包含されたマウス細胞およびインビボにおけるbghの投与法 | |
CA2196555A1 (en) | Vr-2332 viral nucleotide sequence and methods of use | |
ATE100495T1 (de) | Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine. | |
ATE188739T1 (de) | Klonierung hühner-anaemia-virus-dna | |
DE69432500T2 (de) | Rekombinante Foamy-Virus-Vektoren zur medizinischen und diagnostischen Verwendung und Verfahren zur Herstellung rekombinanter Foamy-Virus-Vektoren | |
DE69433823D1 (de) | Interferon gene aus voegeln und rekombinante dna | |
DE69328994T2 (de) | Verfahren zur Herstellung eines fremden Gens oder dessen Produkt in Pflanzenzellen | |
DE69233004D1 (de) | Rekombinanter Virus der Marek-Krankheit, Verfahren zur Herstellung dieses Viruses und diesen enthaltender Impfstoff | |
SE8105516L (sv) | Syntetisk dna och forfarande for framstellning derav | |
CA2037677A1 (en) | Process for production of exogenous gene or its product in plant cells | |
DE69535091D1 (en) | Humane prostacyclinsynthase | |
ATE91717T1 (de) | Verfahren zur herstellung von proteinen in loeslicher form. | |
ATE184915T1 (de) | Verfahren zur herstellung von vakzinen und ihre verwendung | |
WO1997027742B1 (en) | Method of protein production using mitochondrial translation system | |
WO2000037649A3 (en) | Dna vaccine against infectious bursal disease virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |